Epilepsy is a chronic neurological disorder characterized by recurrent seizures. As a prevalent condition affecting over 65 million individuals worldwide, its effective management is a crucial area of interest for healthcare professionals. This article aims to provide an updated overview of the recent advancements in epilepsy management.
Several new antiepileptic drugs (AEDs) have been introduced, offering improved safety profiles and fewer drug interactions. These include Lacosamide, Rufinamide, and Eslicarbazepine. Moreover, Cannabidiol has emerged as a promising adjunctive treatment, particularly for drug-resistant seizures in Lennox-Gastaut syndrome and Dravet syndrome.
Surgical treatments for epilepsy have also seen significant advancements. Minimally invasive techniques such as laser interstitial thermal therapy (LITT) and stereotactic EEG-guided radiofrequency thermocoagulation have shown promising results. These procedures offer the potential for fewer complications and faster recovery times compared to traditional resective surgeries.
Neuromodulation therapies, including Vagus Nerve Stimulation (VNS), Deep Brain Stimulation (DBS), and Responsive Neurostimulation (RNS), have been refined and are increasingly being used as adjunctive treatments for drug-resistant epilepsy. These therapies offer a potential therapeutic option for patients who are not candidates for epilepsy surgery.
With the advent of next-generation sequencing technologies, genetic testing has become more accessible and affordable. This has enabled the identification of specific genetic mutations associated with various forms of epilepsy, paving the way for precision medicine in epilepsy management.
In conclusion, the field of epilepsy management has seen significant advancements in recent years. These have resulted in a broader range of treatment options, offering improved efficacy and safety for patients. Healthcare professionals should stay abreast of these advancements to provide the best possible care for their patients with epilepsy.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation